|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
van Zyl A and Bunn BK: Clinical features
of oral cancer. SADJ. 67:566–569. 2012.
|
|
3
|
Kansy K, Thiele O and Freier K: The role
of human papillomavirus in oral squamous cell carcinoma: Myth and
reality. Oral Maxillofac Surg. 18:165–172. 2014. View Article : Google Scholar
|
|
4
|
Tone Y, Tanahashi N, Tanaka K, Fujimuro M,
Yokosawa H and Toh-e A: Nob1p, a new essential protein, associates
with the 26S proteasome of growing Saccharomyces cerevisiae cells.
Gene. 243:37–45. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tone Y and Toh-E A: Nob1p is required for
biogenesis of the 26S proteasome and degraded upon its maturation
in Saccharomyces cerevisiae. Genes Dev. 16:3142–3157. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fatica A, Oeffinger M, Dlakić M and
Tollervey D: Nob1p is required for cleavage of the 3′ end of 18S
rRNA. Mol Cell Biol. 23:1798–1807. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fatica A, Tollervey D and Dlakić M: PIN
domain of Nob1p is required for D-site cleavage in 20S pre-rRNA.
RNA. 10:1698–1701. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lamanna AC and Karbstein K: Nob1 binds the
single-stranded cleavage site D at the 3′-end of 18S rRNA with its
PIN domain. Proc Natl Acad Sci USA. 106:14259–14264. 2009.
View Article : Google Scholar
|
|
9
|
Zhou GJ, Zhang Y, Wang J, Guo JH, Ni J,
Zhong ZM, Wang LQ, Dang YJ, Dai JF and Yu L: Cloning and
characterization of a novel human RNA binding protein gene PNO1.
DNA Seq. 15:219–224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Ni J, Zhou G, Yuan J, Ren W, Shan
Y, Tang W, Yu L and Zhao S: Cloning, expression and
characterization of the human NOB1 gene. Mol Biol Rep. 32:185–189.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mani A and Gelmann EP: The
ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol.
23:4776–4789. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Montanaro L, Treré D and Derenzini M:
Changes in ribosome biogenesis may induce cancer by downregulating
the cell tumor suppressor potential. Biochim Biophys Acta.
1825:101–110. 2012.
|
|
13
|
Belin S, Beghin A, Solano-Gonzàlez E,
Bezin L, Brunet-Manquat S, Textoris J, Prats AC, Mertani HC,
Dumontet C and Diaz JJ: Dysregulation of ribosome biogenesis and
translational capacity is associated with tumor progression of
human breast cancer cells. PLoS One. 4:e71472009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Deschamps C: Retraction. Up-regulation of
NOB1 in esophageal squamous cell carcinoma (p). Dis Esophagus.
21:5742008. View Article : Google Scholar
|
|
15
|
Li XY, Luo QF, Li J, Wei CK, Kong XJ,
Zhang JF and Fang L: Clinical significance of NOB1 expression in
breast infiltrating ductal carcinoma. Int J Clin Exp Pathol.
6:2137–2144. 2013.PubMed/NCBI
|
|
16
|
Lin S, Meng W, Zhang W, Liu J, Wang P, Xue
S and Chen G: Expression of the NOB1 gene and its clinical
significance in papillary thyroid carcinoma. J Int Med Res.
41:568–572. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu K, Gu MM, Chen HL and You QS: NOB1 in
non-small-cell lung cancer: Expression profile and clinical
significance. Pathol Oncol Res. 20:461–466. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu G, Shen D, Jiao L and Sun Y: Nin one
binding protein expression as a prognostic marker in prostate
carcinoma. Clin Transl Oncol. 16:843–847. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang WY, Chen DH, Ning L and Wang LW:
siRNA mediated silencing of NIN1/RPN12 binding protein 1 homolog
inhibits proliferation and growth of breast cancer cells. Asian Pac
J Cancer Prev. 13:1823–1827. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin Y, Peng S, Yu H, Teng H and Cui M:
RNAi-mediated downregulation of NOB1 suppresses the growth and
colony-formation ability of human ovarian cancer cells. Med Oncol.
29:311–317. 2012. View Article : Google Scholar
|
|
21
|
Lu Z, Guo Q, Shi A, Xie F and Lu Q:
Downregulation of NIN/RPN12 binding protein inhibit the growth of
human hepatocellular carcinoma cells. Mol Biol Rep. 39:501–507.
2012. View Article : Google Scholar
|
|
22
|
Wang H, Li P and Zhao B: Knockdown of NOB1
expression by RNAi inhibits cellular proliferation and migration in
human gliomas. Gene. 528:146–153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen B, Liu J, Wu D, Qin Y, Peng C, Li C
and Wang J: Gene silencing of NOB1 by lentivirus suppresses growth
and migration of human osteosarcoma cells. Mol Med Rep.
9:2173–2179. 2014.PubMed/NCBI
|
|
24
|
Li Y, Ma C, Qian M, Wen Z, Jing H and Qian
D: Downregulation of NOB1 suppresses the proliferation and tumor
growth of non-small cell lung cancer in vitro and in vivo. Oncol
Rep. 31:1271–1276. 2014.PubMed/NCBI
|
|
25
|
Liu Y, Huang H, Yuan B, Zhuang LY, Luo TP
and Zhang Q: Lentivirus-mediated knockdown of NOB1 suppresses the
prolife ration of colon cancer cells. Z Gastroenterol. 52:429–435.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Majchrzak E, Szybiak B, Wegner A,
Pienkowski P, Pazdrowski J, Luczewski L, Sowka M, Golusinski P,
Malicki J and Golusinski W: Oral cavity and oropharyngeal squamous
cell carcinoma in young adults: A review of the literature. Radiol
Oncol. 48:1–10. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou J, Xu T, Yan Y, Qin R, Wang H, Zhang
X, Huang Y, Wang Y, Lu Y, Fu D, et al: MicroRNA-326 functions as a
tumor suppressor in glioma by targeting the Nin one binding protein
(NOB1). PLoS One. 8:e684692013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Polivka J Jr and Janku F: Molecular
targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol
Ther. 142:164–175. 2014. View Article : Google Scholar
|
|
29
|
Kim JE, Lee JI, Jin DH, Lee WJ, Park GB,
Kim S, Kim YS, Wu TC, Hur DY and Kim D: Sequential treatment of HPV
E6 and E7-expressing TC-1 cells with bortezomib and celecoxib
promotes apoptosis through p-p38 MAPK-mediated downregulation of
cyclin D1 and CDK2. Oncol Rep. 31:2429–2437. 2014.PubMed/NCBI
|
|
30
|
Gao LJ, Gu PQ, Zhao W, Ding WY, Zhao XQ,
Guo SY and Zhong TY: The role of globular heads of the C1q receptor
in HPV 16 E2-induced human cervical squamous carcinoma cell
apoptosis is associated with p38 MAPK/JNK activation. J Transl Med.
11:1182013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
El-Mofty SK: Histopathologic risk factors
in oral and oropharyngeal squamous cell carcinoma variants: An
update with special reference to HPV-related carcinomas. Med Oral
Patol Oral Cir Bucal. 19:e377–e385. 2014. View Article : Google Scholar : PubMed/NCBI
|
